ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,886Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 58

$1.7M Total Retail Price of All Prescriptions

Rank: 2 out of 58

636 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 636 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

35% of this provider’s 636 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

6% of this provider’s 6,532 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$132 was the average price of a prescription from this provider, compared to $124 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,297 645 S3 1 2
METHOTREXATE 527 335 2 3
CARISOPRODOL 485 166 R 3 21
PREDNISONE 476 282 4 1
GABAPENTIN 342 202 5 6
OXYCODONE HCL-ACETAMINOPHEN 315 95 S2 6 30
CYMBALTA 289 119 7 10
ZOLPIDEM TARTRATE 266 145 8 12
HYDROXYCHLOROQUINE SULFATE 264 77 9 4
LYRICA 231 71 10 14
TIZANIDINE HCL 211 66 11 23
LEFLUNOMIDE 211 112 11 11
LEVOTHYROXINE SODIUM 208 115 13 22
CELEBREX 198 115 14 13
CYCLOBENZAPRINE HCL 180 89 R 15 15
OXYCONTIN 176 123 S2 16 54
MELOXICAM 166 118 17 7
BACLOFEN 164 62 18 68
FUROSEMIDE 162 115 19 40
TRAMADOL HCL 154 123 20 5
METHADONE HCL 150 30 S2 21 56
OMEPRAZOLE 145 79 22 17
SULINDAC 131 89 23 65
TRIAMTERENE-HCTZ 130 41 24 61
NEXIUM 127 37 25 26
ENDOCET 127 67 S2 25 75
COLCRYS 118 88 27 20
HYDROCHLOROTHIAZIDE 118 61 27 37
AMITRIPTYLINE HCL 115 80 R 29 19
SAVELLA 112 27 30 36
SIMVASTATIN 107 51 31 53
AZATHIOPRINE 105 18 32 31
PANTOPRAZOLE SODIUM 104 77 33 38
IBUPROFEN 101 25 34 50
SULFAMETHOXAZOLE-TRIMETHOPRIM 100 56 35 88
DOXEPIN HCL 100 51 35 88
POTASSIUM CHLORIDE 92 60 37 27
MORPHINE SULFATE ER 92 25 S2 37 72
ALPRAZOLAM 87 69 39 62
ESCITALOPRAM OXALATE 80 30 40 69
ALLOPURINOL 79 31 41 9
LUNESTA 78 36 42 59
WARFARIN SODIUM 75 60 43 98
METHYLPREDNISOLONE 74 28 44 34
FLUOXETINE HCL 73 24 45 100
ENBREL 66 26 46 16
NABUMETONE 65 16 47 24
SYNTHROID 61 27 48 111
PRAMIPEXOLE DIHYDROCHLORIDE 61 35 48 51
OXYCODONE-ACETAMINOPHEN 60 27 S2 50 113
HUMIRA 60 20 50 18
ALENDRONATE SODIUM 59 32 52 8
LIDODERM 59 31 52 57
LISINOPRIL 55 40 54 60
METOPROLOL TARTRATE 54 27 55 121
AMLODIPINE BESYLATE 54 31 55 46
VOLTAREN 53 35 57 35
PRISTIQ ER 53 16 57 123
ATORVASTATIN CALCIUM 52 33 59 85
RANITIDINE HCL 52 31 59 125
DIOVAN 50 39 61 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 6, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.